Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhodopsin | 10 | 1989 | 36 | 0.180 |
Why?
|
| Retinal Pigments | 7 | 1989 | 34 | 0.160 |
Why?
|
| Retinoids | 4 | 1985 | 28 | 0.160 |
Why?
|
| Vitamin A | 5 | 1985 | 87 | 0.140 |
Why?
|
| Teratogens | 2 | 1985 | 11 | 0.130 |
Why?
|
| Retinaldehyde | 7 | 1985 | 21 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 1995 | 157 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 357 | 0.100 |
Why?
|
| HIV-1 | 1 | 1995 | 706 | 0.080 |
Why?
|
| Vision, Ocular | 2 | 1985 | 41 | 0.080 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1985 | 5 | 0.060 |
Why?
|
| Fetus | 1 | 1984 | 105 | 0.060 |
Why?
|
| Vitamin A Deficiency | 1 | 1981 | 13 | 0.050 |
Why?
|
| Retina | 1 | 1981 | 280 | 0.040 |
Why?
|
| Cattle | 7 | 1989 | 477 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 409 | 0.030 |
Why?
|
| Peptide Elongation Factor Tu | 2 | 1994 | 4 | 0.030 |
Why?
|
| Kinetics | 6 | 1991 | 708 | 0.030 |
Why?
|
| Guanosine Diphosphate | 2 | 1994 | 12 | 0.030 |
Why?
|
| Aziridines | 1 | 1995 | 1 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1995 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1994 | 48 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 1995 | 21 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 39 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 112 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 1995 | 43 | 0.030 |
Why?
|
| Guanine Nucleotides | 1 | 1994 | 2 | 0.030 |
Why?
|
| Guanine | 1 | 1994 | 45 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 502 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 60 | 0.030 |
Why?
|
| Ligands | 1 | 1995 | 349 | 0.030 |
Why?
|
| Drug Design | 1 | 1995 | 162 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1995 | 492 | 0.030 |
Why?
|
| Photochemistry | 4 | 1989 | 63 | 0.030 |
Why?
|
| Animals | 11 | 1989 | 15081 | 0.030 |
Why?
|
| Escherichia coli | 2 | 1994 | 453 | 0.030 |
Why?
|
| Cell Survival | 1 | 1995 | 864 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 3 | 1989 | 208 | 0.020 |
Why?
|
| Pregnancy | 2 | 1985 | 1549 | 0.020 |
Why?
|
| Spectrophotometry | 5 | 1989 | 70 | 0.020 |
Why?
|
| Time Factors | 3 | 1989 | 1742 | 0.020 |
Why?
|
| Fetal Resorption | 1 | 1984 | 2 | 0.020 |
Why?
|
| Litter Size | 1 | 1985 | 15 | 0.020 |
Why?
|
| Fetal Death | 1 | 1984 | 18 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1984 | 29 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1985 | 116 | 0.020 |
Why?
|
| Bacteriorhodopsins | 2 | 1984 | 36 | 0.020 |
Why?
|
| Biotransformation | 1 | 1984 | 67 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1984 | 40 | 0.020 |
Why?
|
| Organ Size | 1 | 1985 | 157 | 0.020 |
Why?
|
| Cricetinae | 1 | 1984 | 238 | 0.020 |
Why?
|
| Birth Weight | 1 | 1984 | 90 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1984 | 224 | 0.010 |
Why?
|
| Diterpenes | 2 | 1981 | 92 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 2 | 1994 | 88 | 0.010 |
Why?
|
| Electroretinography | 1 | 1981 | 22 | 0.010 |
Why?
|
| Carotenoids | 1 | 1981 | 70 | 0.010 |
Why?
|
| Light | 3 | 1985 | 187 | 0.010 |
Why?
|
| Binding Sites | 2 | 1994 | 651 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 2 | 1989 | 8 | 0.010 |
Why?
|
| Lasers | 2 | 1989 | 65 | 0.010 |
Why?
|
| Benzopyrans | 1 | 1975 | 14 | 0.010 |
Why?
|
| Mice | 2 | 1985 | 5913 | 0.010 |
Why?
|
| Female | 2 | 1985 | 20969 | 0.010 |
Why?
|
| Male | 3 | 1985 | 20025 | 0.010 |
Why?
|
| Inosine Diphosphate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Oxygen Isotopes | 1 | 1994 | 5 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1994 | 9 | 0.010 |
Why?
|
| Photolysis | 2 | 1985 | 25 | 0.010 |
Why?
|
| Humans | 2 | 1995 | 37093 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1994 | 132 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 1975 | 183 | 0.010 |
Why?
|
| Rats | 1 | 1981 | 3483 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1994 | 216 | 0.010 |
Why?
|
| Schiff Bases | 2 | 1985 | 5 | 0.010 |
Why?
|
| Spectrum Analysis | 2 | 1985 | 54 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1991 | 3 | 0.010 |
Why?
|
| Deuterium | 1 | 1991 | 12 | 0.010 |
Why?
|
| Tritium | 1 | 1991 | 51 | 0.010 |
Why?
|
| Isomerism | 1 | 1989 | 63 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 1180 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1989 | 217 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1985 | 37 | 0.000 |
Why?
|
| Vibration | 1 | 1985 | 23 | 0.000 |
Why?
|
| Fourier Analysis | 1 | 1985 | 43 | 0.000 |
Why?
|
| Protons | 1 | 1985 | 84 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1983 | 167 | 0.000 |
Why?
|
| Freezing | 1 | 1981 | 16 | 0.000 |
Why?
|
| Halobacterium | 1 | 1981 | 19 | 0.000 |
Why?
|
| Darkness | 1 | 1981 | 27 | 0.000 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1975 | 4 | 0.000 |
Why?
|
| Hemoglobin, Sickle | 1 | 1975 | 13 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 972 | 0.000 |
Why?
|
| Models, Biological | 1 | 1979 | 677 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1975 | 111 | 0.000 |
Why?
|
| Oxygen | 1 | 1975 | 207 | 0.000 |
Why?
|